{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:39:55Z","timestamp":1789609195218,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.transci.2013.02.043","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T13:00:35Z","timestamp":1372510835000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Therapeutic plasma exchange in treatment of neuroimmunologic disorders: Review of 92 cases"],"prefix":"10.1016","volume":"49","author":[{"given":"Mine Hayriye","family":"Sorgun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyda","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Ayy\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nezih","family":"Y\u00fccemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"IIhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Y\u00fccesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2013.02.043_b0005","series-title":"Current therapy in neurologic disease","first-page":"421","article-title":"Intravenous Immunglobulin and Plasmapheresis in the Treatment of Neurologic Disease","author":"Johnson","year":"2006"},{"key":"10.1016\/j.transci.2013.02.043_b0010","series-title":"Principles of neurology","first-page":"1110","article-title":"Diseases of the peripheral nerves","author":"Victor","year":"2005"},{"key":"10.1016\/j.transci.2013.02.043_b0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-0404.1999.tb07336.x","article-title":"Plasmapheresis in myasthenia gravis","volume":"99","author":"Yeh","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.transci.2013.02.043_b0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.transci.2006.06.008","article-title":"Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases","volume":"36","author":"Yucesan","year":"2007","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.transci.2013.02.043_b0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-2008-1062261","article-title":"Guillain Barre\u2019 syndrome","volume":"28","author":"Burns","year":"2008","journal-title":"Semin Neurol"},{"key":"10.1016\/j.transci.2013.02.043_b0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.transci.2007.11.002","article-title":"Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study","volume":"38","author":"Kaynar","year":"2008","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.transci.2013.02.043_b0035","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","author":"Skeie","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.transci.2013.02.043_b0040","doi-asserted-by":"crossref","unstructured":"Gajdos P, Chevret S, Toyka K. Plasma exchange for myasthenia gravis and Intravenous immunoglobulin for myasthenia gravis. The Cochrane Library, No. 1, Article ID CD002277; 2009.","DOI":"10.1002\/14651858.CD002277.pub3"},{"key":"10.1016\/j.transci.2013.02.043_b0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.46.1.100","article-title":"Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barr\u00e9 Syndrome","volume":"46","author":"Bril","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2013.02.043_b0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","article-title":"Guillain-Barr\u00e9 syndrome: an update","volume":"16","author":"Vucic","year":"2009","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.transci.2013.02.043_b0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1998.tb01952.x","article-title":"Safety of plasmapheresis in the treatment of neurologic disease","volume":"28","author":"Vucic","year":"1998","journal-title":"Aust NZ J Med"},{"key":"10.1016\/j.transci.2013.02.043_b0060","first-page":"478","article-title":"Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital","volume":"92","author":"Pittayanon","year":"2009","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.transci.2013.02.043_b0065","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"Barth","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2013.02.043_b0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-2008-1062260","article-title":"Autoimmune disorders of neuromuscular transmission","volume":"28","author":"Mahade","year":"2008","journal-title":"Semin Neurol"},{"key":"10.1016\/j.transci.2013.02.043_b0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2003-41135","article-title":"Theapy in myastenia gravis and Lambert Eaton myasthenic syndrome","volume":"23","author":"Newsom Davis","year":"2003","journal-title":"Semin Neurol"},{"key":"10.1016\/j.transci.2013.02.043_b0080","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy","volume":"119","author":"Hanh","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.transci.2013.02.043_b0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","article-title":"Plasma-exchange in chronic inflammatory demyelinating polyneuropathy","volume":"314","author":"Dyck","year":"1986","journal-title":"N Eng J Med"},{"key":"10.1016\/j.transci.2013.02.043_b0090","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1468-1331.2011.03495.x","article-title":"Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis","volume":"18","author":"Cocito","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.transci.2013.02.043_b0095","first-page":"CD003906","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"3","author":"Mehndiratta","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transci.2013.02.043_b0100","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","article-title":"A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"36","author":"Dyck","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.transci.2013.02.043_b0105","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q","article-title":"Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome","volume":"22","author":"Saperstein","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.transci.2013.02.043_b0110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/(SICI)1097-4598(199906)22:6<758::AID-MUS13>3.0.CO;2-N","article-title":"Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy","volume":"22","author":"Gorson","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.transci.2013.02.043_b0115","first-page":"362","article-title":"Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy?","volume":"2","author":"Oh","year":"1997","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.transci.2013.02.043_b0120","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/WNL.42.3.536","article-title":"Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies","volume":"42","author":"Graus","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2013.02.043_b0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tmrv.2007.01.002","article-title":"Guidelines on the use of intravenous immune globulin for neurologic conditions","volume":"21","author":"Feasby","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2013.02.043_b0130","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/jnnp.37.7.848","article-title":"Toxic polyneuropathy due to glue sniffing","volume":"37","author":"Goto","year":"1974","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.transci.2013.02.043_b0135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000052142","article-title":"Plasmapheresis in the treatment of ataxic sensory neuropathy associated with Sj\u00f6gren\u2019s syndrome","volume":"45","author":"Chen","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.transci.2013.02.043_b0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","article-title":"Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange","volume":"366","author":"Keegan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2013.02.043_b0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-510X(00)00260-4","article-title":"Acute disseminated encephalomyelitis in a pregnant woman successfully treated with plasmapheresis","volume":"174","author":"Shah","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.transci.2013.02.043_b0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1352458506071174","article-title":"Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica","volume":"13","author":"Watanabe","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.transci.2013.02.043_b0155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.0b013e3181b879be","article-title":"Plasma exchange in acute attacks of CNS demyelination: predictors of improvement","volume":"73","author":"Llufriu","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2013.02.043_b0160","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1212\/01.wnl.0000260970.63493.c8","article-title":"Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide","volume":"68","author":"Greenberg","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2013.02.043_b0165","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3899\/jrheum.080268","article-title":"Antiphospholipid antibody-associated chorea","volume":"35","author":"Orzechowski","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.transci.2013.02.043_b0170","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/mds.23863","article-title":"Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies","volume":"26","author":"Reiner","year":"2011","journal-title":"Movement Disord"},{"key":"10.1016\/j.transci.2013.02.043_b0175","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1469-8749.2011.03922.x","article-title":"Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies","volume":"53","author":"Dale","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.transci.2013.02.043_b0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transci.2004.02.007","article-title":"Therapeutic plasma exchange in a single center: Ibni Sina experience","volume":"30","author":"Arslan","year":"2004","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.transci.2013.02.043_b0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.transci.2007.01.008","article-title":"Therapeutic apheresis for myositises","volume":"36","author":"Le Guern","year":"2007","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.transci.2013.02.043_b0190","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2008.02246.x","article-title":"EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases","volume":"15","author":"Elovaara","year":"2008","journal-title":"Eur J Neurol"},{"issue":"4 Pt 2","key":"10.1016\/j.transci.2013.02.043_b0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.lpm.2010.12.012","article-title":"Therapy of polymyositis and dermatomyositis","volume":"40","author":"Marie","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.transci.2013.02.043_b0200","first-page":"63","article-title":"Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration","volume":"58","author":"Basi\u0107-Juki\u0107","year":"2004","journal-title":"Acta Med Croatica"},{"key":"10.1016\/j.transci.2013.02.043_b0205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1744-9987.2007.00546.x","article-title":"A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers","volume":"12","author":"Landtblom","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2013.02.043_b0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-510X(02)00188-0","article-title":"Successful immune treatment for non-paraneoplastic limbic encephalitis","volume":"201","author":"Mori","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.transci.2013.02.043_b0215","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/jnnp.2009.178293","article-title":"An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis","volume":"81","author":"Wong","year":"2010","journal-title":"J Neurol Neurosurg Psychia"},{"key":"10.1016\/j.transci.2013.02.043_b0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2169\/internalmedicine.49.2821","article-title":"Successful treatment with rituximab in a patient with stiff-person syndrome complicated by dysthyroid ophthalmopathy","volume":"49","author":"Katoh","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.transci.2013.02.043_b0225","first-page":"1003","article-title":"Familial amyotrophic lateral sclerosis with rapid progression","volume":"57","author":"Oyama","year":"2005","journal-title":"No To Shinkei"},{"key":"10.1016\/j.transci.2013.02.043_b0230","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1744-9987.2005.00319.x","article-title":"Complications of therapeutic plasma exchange: experience with 4857 treatments","volume":"9","author":"Basic-Jukic","year":"2005","journal-title":"Ther Apher Dial"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213002115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213002115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T15:08:43Z","timestamp":1563289723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050213002115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1473050213002115"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2013.02.043","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic plasma exchange in treatment of neuroimmunologic disorders: Review of 92 cases","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2013.02.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}